Vivos Inc. – OTC:RDGL
Vivos stock price today
Vivos stock price monthly change
Vivos stock price quarterly change
Vivos stock price yearly change
Vivos key metrics
Market Cap | 24.69M |
Enterprise value | N/A |
P/E | -7 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | 624.93 |
Price/Book | 13.73 |
PEG ratio | -0.29 |
EPS | N/A |
Revenue | 25.53K |
EBITDA | -3.12M |
Income | -3.20M |
Revenue Q/Q | -25% |
Revenue Y/Y | -13.43% |
Profit margin | -6767.75% |
Oper. margin | -6898.13% |
Gross margin | 21.15% |
EBIT margin | -6898.13% |
EBITDA margin | -12225.71% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeVivos stock price history
Vivos stock forecast
Vivos financial statements
| Jun 2023 | 6.5K | -902.52K | -13885.02% |
|---|---|---|---|
| Sep 2023 | 7K | -667.69K | -9538.43% |
| Dec 2023 | 7.53K | -1.07M | -14281.04% |
| Mar 2024 | 4.5K | -558.53K | -12411.98% |
| Jun 2023 | 1789650 | 112.81K | 6.3% |
|---|---|---|---|
| Sep 2023 | 1566519 | 107.36K | 6.85% |
| Dec 2023 | 1610124 | 245.00K | 15.22% |
| Mar 2024 | 1382329 | 74.76K | 5.41% |
| Jun 2023 | -314.33K | 0 | 650.66K |
|---|---|---|---|
| Sep 2023 | -221.92K | 0 | 10K |
| Dec 2023 | -463.13K | 0 | 518.58K |
| Mar 2024 | -351.45K | 0 | 130K |
Vivos alternative data
| Aug 2023 | 1 |
|---|---|
| Sep 2023 | 1 |
| Oct 2023 | 1 |
| Nov 2023 | 1 |
| Dec 2023 | 1 |
| Jan 2024 | 1 |
| Feb 2024 | 1 |
| Mar 2024 | 1 |
| Apr 2024 | 1 |
| May 2024 | 1 |
| Jun 2024 | 1 |
| Jul 2024 | 1 |
Vivos other data
| Period | Buy | Sel |
|---|---|---|
| Oct 2023 | 100000 | 0 |
| Nov 2023 | 100000 | 0 |
| Jun 2024 | 50000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | KORENKO MICHAEL K director, officer.. | Common Stock | 50,000 | $0.17 | $8,450 | ||
Purchase | KORENKO MICHAEL K director, officer.. | Common Stock | 100,000 | $0.05 | $5,200 | ||
Purchase | KORENKO MICHAEL K director, officer.. | Common Stock | 100,000 | $0.05 | $5,400 | ||
Sale | POLLACK MICHAEL H officer: INTERIM CFO | Common Stock | 16,000 | $0.06 | $992 | ||
Purchase | KORENKO MICHAEL K director, officer.. | Common Stock | 100,000 | $0.05 | $4,700 | ||
Purchase | KORENKO MICHAEL K director, officer.. | Common Stock | 200,000 | $0.05 | $10,400 | ||
Purchase | KORENKO MICHAEL K director, officer.. | Common Stock | 200,000 | $0.07 | $14,000 | ||
Purchase | KORENKO MICHAEL K director, officer.. | Common Stock | 100,000 | $0.06 | $6,200 | ||
Option | KORENKO MICHAEL K director, officer.. | Warrant (Right to buy) | 75,000 | $0.05 | $3,375 | ||
Option | KORENKO MICHAEL K director, officer.. | Common Stock | 22,266 | N/A | N/A |
| Insider | Compensation |
|---|---|
| Dr. Michael K. Korenko (1946) Chief Executive Officer, Pres & Director | $218,250 |
-
What's the price of Vivos stock today?
One share of Vivos stock can currently be purchased for approximately $0.08.
-
When is Vivos's next earnings date?
Unfortunately, Vivos's (RDGL) next earnings date is currently unknown.
-
Does Vivos pay dividends?
No, Vivos does not pay dividends.
-
How much money does Vivos make?
Vivos has a market capitalization of 24.69M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 46.57% to 19.5K US dollars.
-
What is Vivos's stock symbol?
Vivos Inc. is traded on the OTC under the ticker symbol "RDGL".
-
What is Vivos's primary industry?
Company operates in the Healthcare sector and Medical Devices industry.
-
How do i buy shares of Vivos?
Shares of Vivos can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Vivos's key executives?
Vivos's management team includes the following people:
- Dr. Michael K. Korenko Chief Executive Officer, Pres & Director(age: 79, pay: $218,250)
-
How many employees does Vivos have?
As Jul 2024, Vivos employs 1 workers.
-
When Vivos went public?
Vivos Inc. is publicly traded company for more then 24 years since IPO on 20 Aug 2001.
-
What is Vivos's official website?
The official website for Vivos is radiogel.com.
-
Where are Vivos's headquarters?
Vivos is headquartered at 719 Jadwin Avenue, Richland, WA.
-
How can i contact Vivos?
Vivos's mailing address is 719 Jadwin Avenue, Richland, WA and company can be reached via phone at +509 7364000.
Vivos company profile:
Vivos Inc.
radiogel.comOTC
1
Medical Devices
Healthcare
Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.
Richland, WA 99352
CIK: 0001449349
ISIN: US92858K2042
CUSIP: 92858K204
